| Glaxosmithkline Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500660 |
NSE Symbol : GLAXO |
P/E(TTM) : 54.21 |
|
ISIN Demat : INE159A01016 |
Div & Yield% : 1.26 |
EPS(TTM) : 46.98 |
|
Book Value(₹) : 98.85 |
Market Cap(₹Cr) : 43,147.72 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 1,000.05 | 811.00 | 910.87 | 804.98 | 953.38 | 738.02 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,000.05 | 811.00 | 910.87 | 804.98 | 953.38 | 738.02 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 36.88 | 35.85 | 32.27 | 28.34 | 28.47 | 54.10 |
| Total Income | 1,036.93 | 846.85 | 943.14 | 833.32 | 981.85 | 792.12 |
| Total Expenditure | 681.10 | 581.58 | 655.56 | 750.78 | 666.80 | 596.77 |
| PBIDT | 355.83 | 265.27 | 287.58 | 82.54 | 315.05 | 195.35 |
| Interest | 0.27 | 0.37 | 0.77 | 0.32 | 0.43 | 0.28 |
| PBDT | 355.56 | 264.90 | 286.81 | 82.22 | 314.62 | 195.07 |
| Depreciation | 16.86 | 16.41 | 18.10 | 17.11 | 18.11 | 16.36 |
| Tax | 97.46 | 63.33 | 61.16 | 31.32 | 90.60 | 52.63 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -7.45 | 3.51 | 14.47 | -11.70 | -9.63 | -4.50 |
| Reported Profit After Tax | 248.69 | 181.65 | 193.08 | 45.49 | 215.54 | 130.58 |
| Extra-ordinary Items | 3.34 | 0.00 | 1.72 | -131.99 | 0.00 | 12.21 |
| Adjusted Profit After Extra-ordinary item | 245.35 | 181.65 | 191.36 | 177.48 | 215.54 | 118.37 |
| EPS (Unit Curr.) | 14.45 | 10.72 | 11.29 | 2.69 | 12.72 | 6.94 |
| EPS (Adj) (Unit Curr.) | 14.45 | 10.72 | 11.29 | 2.69 | 12.72 | 6.94 |
| Calculated EPS (Unit Curr.) | 14.68 | 10.72 | 11.40 | 2.69 | 12.72 | 7.71 |
| Calculated EPS (Adj) (Unit Curr.) | 14.68 | 10.72 | 11.40 | 2.69 | 12.72 | 7.71 |
| Calculated EPS (Ann.) (Unit Curr.) | 58.72 | 42.89 | 45.59 | 10.74 | 50.89 | 30.83 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 58.72 | 42.89 | 45.59 | 10.74 | 50.89 | 30.83 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 120.00 | 0.00 | 0.00 | 0.00 | 320.00 | 0.00 |
| Equity | 169.41 | 169.41 | 169.41 | 169.41 | 169.41 | 169.41 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 35.58 | 32.71 | 31.57 | 10.25 | 33.05 | 26.47 |
| PBDTM(%) | 35.55 | 32.66 | 31.49 | 10.21 | 33.00 | 26.43 |
| PATM(%) | 24.87 | 22.40 | 21.20 | 5.65 | 22.61 | 17.69 |